These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 33281941)

  • 1. The gut microbiome: an under-recognised contributor to the COVID-19 pandemic?
    Segal JP; Mak JWY; Mullish BH; Alexander JL; Ng SC; Marchesi JR
    Therap Adv Gastroenterol; 2020; 13():1756284820974914. PubMed ID: 33281941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut microbiome, Vitamin D, ACE2 interactions are critical factors in immune-senescence and inflammaging: key for vaccine response and severity of COVID-19 infection.
    Shenoy S
    Inflamm Res; 2022 Jan; 71(1):13-26. PubMed ID: 34738147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoimmunity and COVID-19 - The microbiotal connection.
    Katz-Agranov N; Zandman-Goddard G
    Autoimmun Rev; 2021 Aug; 20(8):102865. PubMed ID: 34118455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut microbiota in COVID-19: key microbial changes, potential mechanisms and clinical applications.
    Zhang F; Lau RI; Liu Q; Su Q; Chan FKL; Ng SC
    Nat Rev Gastroenterol Hepatol; 2023 May; 20(5):323-337. PubMed ID: 36271144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of COVID-19 on the Intestinal Microbiome.
    Venegas-Borsellino C; Sankararaman S; Roche K; Burns J; Landis RM
    Curr Nutr Rep; 2021 Dec; 10(4):300-306. PubMed ID: 34813042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19).
    Bourgonje AR; Abdulle AE; Timens W; Hillebrands JL; Navis GJ; Gordijn SJ; Bolling MC; Dijkstra G; Voors AA; Osterhaus AD; van der Voort PH; Mulder DJ; van Goor H
    J Pathol; 2020 Jul; 251(3):228-248. PubMed ID: 32418199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization.
    Zuo T; Zhang F; Lui GCY; Yeoh YK; Li AYL; Zhan H; Wan Y; Chung ACK; Cheung CP; Chen N; Lai CKC; Chen Z; Tso EYK; Fung KSC; Chan V; Ling L; Joynt G; Hui DSC; Chan FKL; Chan PKS; Ng SC
    Gastroenterology; 2020 Sep; 159(3):944-955.e8. PubMed ID: 32442562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Taxonomical and functional changes in COVID-19 faecal microbiome could be related to SARS-CoV-2 faecal load.
    Grenga L; Pible O; Miotello G; Culotta K; Ruat S; Roncato MA; Gas F; Bellanger L; Claret PG; Dunyach-Remy C; Laureillard D; Sotto A; Lavigne JP; Armengaud J
    Environ Microbiol; 2022 Sep; 24(9):4299-4316. PubMed ID: 35506300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of microbiota in the gut and upper respiratory tract associated with SARS-CoV-2 infection.
    Li J; Jing Q; Li J; Hua M; Di L; Song C; Huang Y; Wang J; Chen C; Wu AR
    Microbiome; 2023 Mar; 11(1):38. PubMed ID: 36869345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal landscape of human gut RNA and DNA virome in SARS-CoV-2 infection and severity.
    Zuo T; Liu Q; Zhang F; Yeoh YK; Wan Y; Zhan H; Lui GCY; Chen Z; Li AYL; Cheung CP; Chen N; Lv W; Ng RWY; Tso EYK; Fung KSC; Chan V; Ling L; Joynt G; Hui DSC; Chan FKL; Chan PKS; Ng SC
    Microbiome; 2021 Apr; 9(1):91. PubMed ID: 33853691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastrointestinal Manifestations of SARS-CoV-2: Transmission, Pathogenesis, Immunomodulation, Microflora Dysbiosis, and Clinical Implications.
    Durairajan SSK; Singh AK; Saravanan UB; Namachivayam M; Radhakrishnan M; Huang JD; Dhodapkar R; Zhang H
    Viruses; 2023 May; 15(6):. PubMed ID: 37376531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut microbiome dynamics and predictive value in hospitalized COVID-19 patients: a comparative analysis of shallow and deep shotgun sequencing.
    Kopera K; Gromowski T; Wydmański W; Skonieczna-Żydecka K; Muszyńska A; Zielińska K; Wierzbicka-Woś A; Kaczmarczyk M; Kadaj-Lipka R; Cembrowska-Lech D; Januszkiewicz K; Kotfis K; Witkiewicz W; Nalewajska M; Feret W; Marlicz W; Łoniewski I; Łabaj PP; Rydzewska G; Kosciolek T
    Front Microbiol; 2024; 15():1342749. PubMed ID: 38962119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of ACE, AGTR1, and ACE2 genes mediating SARS-CoV-2 pathogenesis by gut microbiota members and their postbiotics on Caco-2 cells.
    Ahmadi Badi S; Malek A; Paolini A; Rouhollahi Masoumi M; Seyedi SA; Amanzadeh A; Masotti A; Khatami S; Siadat SD
    Microb Pathog; 2022 Dec; 173(Pt A):105798. PubMed ID: 36174833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Gut Microbiome in COVID-19: An Insight Into Pathogenesis and Therapeutic Potential.
    Hussain I; Cher GLY; Abid MA; Abid MB
    Front Immunol; 2021; 12():765965. PubMed ID: 34721437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between gut microbiota and COVID-19 progression: new insights into immunopathogenesis and treatment.
    Wang M; Zhang Y; Li C; Chang W; Zhang L
    Front Immunol; 2023; 14():1180336. PubMed ID: 37205106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 and the neonatal microbiome: will the pandemic cost infants their microbes?
    Romano-Keeler J; Zhang J; Sun J
    Gut Microbes; 2021; 13(1):1-7. PubMed ID: 33960272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 and immune-microbiome interactions: Lessons from respiratory viral infections.
    Cyprian F; Sohail MU; Abdelhafez I; Salman S; Attique Z; Kamareddine L; Al-Asmakh M
    Int J Infect Dis; 2021 Apr; 105():540-550. PubMed ID: 33610778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current Drug Targets for Gut Microbiota Biocorrection during the SARS-CoV-2 Pandemic: A Systematic Review.
    Sankova MV; Nikolenko VN; Oganesyan MV; Bakhmet AA; Gavryushova LV; Sankov SV; Sinelnikov MY
    Curr Drug Targets; 2022; 23(11):1099-1125. PubMed ID: 35440305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations in microbiome of COVID-19 patients and its impact on forensic investigations.
    Mir TUG; Manhas S; Khurshid Wani A; Akhtar N; Shukla S; Prakash A
    Sci Justice; 2024 Jan; 64(1):81-94. PubMed ID: 38182316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.